Although the E3 ligase that targets BRCA1 for proteolysis remains unknown, the enhanced degradation of BRCA1 by a deregulated E3 ligase could be one of the mechanisms by which BRCA1 levels are reduced in sporadic breast cancer [20], [21]. Here, BRCA1 is linked to breast carcinoma.